Literature DB >> 8277509

Structure-activity relationships of the antimalarial agent artemisinin. 1. Synthesis and comparative molecular field analysis of C-9 analogs of artemisinin and 10-deoxoartemisinin.

M A Avery1, F Gao, W K Chong, S Mehrotra, W K Milhous.   

Abstract

A series of C-9 beta-substituted artemisinin analogs (2-21) were synthesized via dianion alkylation of the total synthetic intermediate 57 followed by subsequent ozonolysis/acidification, or by alkylation of the enolate derived from (+)-9-desmethylartemisinin, 2. Inactive acyclic analogs 22 and 23 were synthesized by nucleophilic epoxide opening and the ring contracted analog 24 was prepared by an alternate route. 10-Deoxo-9-alkyl derivatives 68 and 70 were synthesized convergently from intermediates in the preparation of 9-alkyl derivatives. In vitro bioassay was conducted in W-2 and D-6 clones of drug resistant Plasmodium falciparum. Comparative molecular field analysis (CoMFA) of the 9-alkyl lactone derivatives provided a model with a cross-validated r2 = 0.793. Inclusion of inactive 1-deoxyartemisinin analogs 26-42 provided a model with a value of 0.857. The activities of a number of other analogs of divergent structure (43-56) were predicted with good accuracy using the CoMFA model.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8277509     DOI: 10.1021/jm00078a017

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  13 in total

1.  In vitro activities of DU-1102, a new trioxaquine derivative, against Plasmodium falciparum isolates.

Authors:  L K Basco; O Dechy-Cabaret; M Ndounga; F S Meche; A Robert; B Meunier
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Comparative molecular field analysis of artemisinin derivatives: ab initio versus semiempirical optimized structures.

Authors:  S Tonmunphean; S Kokpol; V Parasuk; P Wolschann; R H Winger; K R Liedl; B M Rode
Journal:  J Comput Aided Mol Des       Date:  1998-07       Impact factor: 3.686

3.  Comparison of 3D quantitative structure-activity relationship methods: analysis of the in vitro antimalarial activity of 154 artemisinin analogues by hypothetical active-site lattice and comparative molecular field analysis.

Authors:  J R Woolfrey; M A Avery; A M Doweyko
Journal:  J Comput Aided Mol Des       Date:  1998-03       Impact factor: 3.686

Review 4.  Natural Products in the "Marketplace": Interfacing Synthesis and Biology.

Authors:  Benjamin J Huffman; Ryan A Shenvi
Journal:  J Am Chem Soc       Date:  2019-02-13       Impact factor: 15.419

5.  Computational study of antimalarial pyrazole alkaloids from Newbouldia laevis.

Authors:  Liliana Mammino; Mireille K Bilonda
Journal:  J Mol Model       Date:  2014-10-29       Impact factor: 1.810

6.  Replacement of steric 6-12 potential-derived interaction energies by atom-based indicator variables in CoMFA leads to models of higher consistency.

Authors:  R T Kroemer; P Hecht
Journal:  J Comput Aided Mol Des       Date:  1995-06       Impact factor: 3.686

7.  A new procedure for improving the predictiveness of CoMFA models and its application to a set of dihydrofolate reductase inhibitors.

Authors:  R T Kroemer; P Hecht
Journal:  J Comput Aided Mol Des       Date:  1995-10       Impact factor: 3.686

Review 8.  Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy.

Authors:  S R Meshnick; T E Taylor; S Kamchonwongpaisan
Journal:  Microbiol Rev       Date:  1996-06

Review 9.  Progress in the research of artemisinin-related antimalarials: an update.

Authors:  H J Woerdenbag; N Pras; W van Uden; T E Wallaart; A C Beekman; C B Lugt
Journal:  Pharm World Sci       Date:  1994-08-05

10.  Molecular modeling and evaluation of binding mode and affinity of artemisinin-quinine hybrid and its congeners with Fe-protoporphyrin-IX as a putative receptor.

Authors:  Rajani Kanta Mahapatra; Niranjan Behera; Pradeep Kumar Naik
Journal:  Bioinformation       Date:  2012-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.